Literature DB >> 21203981

The role of BRCA1 in DNA damage response.

Jiaxue Wu1, Lin-Yu Lu, Xiaochun Yu.   

Abstract

BRCA1 is a well-established tumor suppressor gene, which is frequently mutated in familial breast and ovarian cancers. The gene product of BRCA1 functions in a number of cellular pathways that maintain genomic stability, including DNA damage-induced cell cycle checkpoint activation, DNA damage repair, protein ubiquitination, chromatin remodeling, as well as transcriptional regulation and apoptosis. In this review, we discuss recent advances regarding our understanding of the role of BRCA1 in tumor suppression and DNA damage response, including DNA damage-induced cell cycle checkpoint activation and DNA damage repair.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21203981      PMCID: PMC3078634          DOI: 10.1007/s13238-010-0010-5

Source DB:  PubMed          Journal:  Protein Cell        ISSN: 1674-800X            Impact factor:   14.870


  96 in total

1.  Cdc2 tyrosine phosphorylation is required for the DNA damage checkpoint in fission yeast.

Authors:  N Rhind; B Furnari; P Russell
Journal:  Genes Dev       Date:  1997-02-15       Impact factor: 11.361

Review 2.  DNA breakage and repair.

Authors:  P A Jeggo
Journal:  Adv Genet       Date:  1998       Impact factor: 1.944

3.  Chk1 is a wee1 kinase in the G2 DNA damage checkpoint inhibiting cdc2 by Y15 phosphorylation.

Authors:  M J O'Connell; J M Raleigh; H M Verkade; P Nurse
Journal:  EMBO J       Date:  1997-02-03       Impact factor: 11.598

4.  Dynamic changes of BRCA1 subnuclear location and phosphorylation state are initiated by DNA damage.

Authors:  R Scully; J Chen; R L Ochs; K Keegan; M Hoekstra; J Feunteun; D M Livingston
Journal:  Cell       Date:  1997-08-08       Impact factor: 41.582

Review 5.  Epidemiology, prevention, and early detection of breast cancer.

Authors:  A J Alberg; K J Helzlsouer
Journal:  Curr Opin Oncol       Date:  1997-11       Impact factor: 3.645

6.  Association of BRCA1 with the hRad50-hMre11-p95 complex and the DNA damage response.

Authors:  Q Zhong; C F Chen; S Li; Y Chen; C C Wang; J Xiao; P L Chen; Z D Sharp; W H Lee
Journal:  Science       Date:  1999-07-30       Impact factor: 47.728

Review 7.  S phase damage sensing checkpoints in mammalian cells.

Authors:  J M Larner; H Lee; J L Hamlin
Journal:  Cancer Surv       Date:  1997

8.  Conditional mutation of Brca1 in mammary epithelial cells results in blunted ductal morphogenesis and tumour formation.

Authors:  X Xu; K U Wagner; D Larson; Z Weaver; C Li; T Ried; L Hennighausen; A Wynshaw-Boris; C X Deng
Journal:  Nat Genet       Date:  1999-05       Impact factor: 38.330

Review 9.  Breast cancer susceptibility genes. BRCA1 and BRCA2.

Authors:  L C Brody; B B Biesecker
Journal:  Medicine (Baltimore)       Date:  1998-05       Impact factor: 1.889

10.  Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase.

Authors:  Helen E Bryant; Niklas Schultz; Huw D Thomas; Kayan M Parker; Dan Flower; Elena Lopez; Suzanne Kyle; Mark Meuth; Nicola J Curtin; Thomas Helleday
Journal:  Nature       Date:  2005-04-14       Impact factor: 69.504

View more
  90 in total

1.  The C-terminal proteolytic fragment of the breast cancer susceptibility type 1 protein (BRCA1) is degraded by the N-end rule pathway.

Authors:  Zhizhong Xu; Roshani Payoe; Richard P Fahlman
Journal:  J Biol Chem       Date:  2012-01-18       Impact factor: 5.157

2.  Disentangling the aging gene expression network of termite queens.

Authors:  José Manuel Monroy Kuhn; Karen Meusemann; Judith Korb
Journal:  BMC Genomics       Date:  2021-05-11       Impact factor: 3.969

3.  F1 hybrids of BALB/c and C57BL/6 mouse strains respond differently to low-dose ionizing radiation exposure.

Authors:  Sanjay Mukherjee; K B Sainis; Deepti D Deobagkar
Journal:  J Genet       Date:  2014-12       Impact factor: 1.166

4.  β-Hydroxybutyrate Prevents Vascular Senescence through hnRNP A1-Mediated Upregulation of Oct4.

Authors:  Young-Min Han; Tatiana Bedarida; Ye Ding; Brian K Somba; Qiulun Lu; Qilong Wang; Ping Song; Ming-Hui Zou
Journal:  Mol Cell       Date:  2018-09-06       Impact factor: 17.970

5.  BRCA1 promotes unloading of the CMG helicase from a stalled DNA replication fork.

Authors:  David T Long; Vladimir Joukov; Magda Budzowska; Johannes C Walter
Journal:  Mol Cell       Date:  2014-09-11       Impact factor: 17.970

6.  DNA Damage Follows Repair Factor Depletion and Portends Genome Variation in Cancer Cells after Pore Migration.

Authors:  Jerome Irianto; Yuntao Xia; Charlotte R Pfeifer; Avathamsa Athirasala; Jiazheng Ji; Cory Alvey; Manu Tewari; Rachel R Bennett; Shane M Harding; Andrea J Liu; Roger A Greenberg; Dennis E Discher
Journal:  Curr Biol       Date:  2016-12-15       Impact factor: 10.834

Review 7.  Proteomic Analysis of the Downstream Signaling Network of PARP1.

Authors:  Yuanli Zhen; Yonghao Yu
Journal:  Biochemistry       Date:  2018-01-19       Impact factor: 3.162

8.  A new genetically engineered mouse model of choroid plexus carcinoma.

Authors:  Salsabiel El Nagar; Frederique Zindy; Charlotte Moens; Luc Martin; Damien Plassard; Martine F Roussel; Thomas Lamonerie; Nathalie Billon
Journal:  Biochem Biophys Res Commun       Date:  2018-01-12       Impact factor: 3.575

9.  BRCA1 deficiency in ovarian cancer is associated with alteration in expression of several key regulators of cell motility - A proteomics study.

Authors:  David M Gau; Jamie L Lesnock; Brian L Hood; Rohit Bhargava; Mai Sun; Kathleen Darcy; Soumya Luthra; Uma Chandran; Thomas P Conrads; Robert P Edwards; Joseph L Kelley; Thomas C Krivak; Partha Roy
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

Review 10.  HMGA2 and high-grade serous ovarian carcinoma.

Authors:  Jingjing Wu; Jian-Jun Wei
Journal:  J Mol Med (Berl)       Date:  2013-05-19       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.